Eicosapentaenoic Acid for the Prevention of Recurrent Atrial Fibrillation

Author： Watanabe Eiichi Sobue Yoshihiro Sano Kan Okuda Kentarou Yamamoto Mayumi Ozaki Yukio

ISSN： 1082-720X

Source： Annals of Noninvasive Electrocardiology, Vol.16, Iss.4, 2011-10, pp. : 373-378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dronedarone: A New Hope for Stroke Prevention in Atrial Fibrillation?

By Shantsila Alena Lip Gregory Y.H.

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 355-356

Adis International

Access to resources Recommend Favorite

Angiotensin II receptor blockers in the prevention of atrial fibrillation

By Barra Silvia Silvestri Nunzia Vitagliano Giancarlo Madrid Alfredo Gaeta Giovanni

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1395-1411

Informa Healthcare

Access to resources Recommend Favorite

Stroke Prevention in Atrial Fibrillation: Putting the Guidelines into Practice

By Mant Jonathan Edwards Duncan

Drugs & Aging, Vol. 27, Iss. 11, 2010-11 ,pp. : 859-870

Adis International

Access to resources Recommend Favorite

Guidelines for Stroke Prevention in Patients with Atrial Fibrillation

By Howard P.A.

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 997-1009

Adis International

Access to resources Recommend Favorite

Ximelagatran Cost Effectiveness for Stroke Prevention in Atrial Fibrillation

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 4, 2005-12 ,pp. : 279-283

John Wiley & Sons Inc

Access to resources Recommend Favorite